MDMB-4en-PINACA

MDMB-4en-PINACA is a synthetic cannabinoid that has been used as a designer drug. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system in the human body. This compound is often found in "spice" or "K2" products, which are marketed as legal alternatives to cannabis.
Chemical Structure and Properties[edit]
MDMB-4en-PINACA is classified as an indazole-based synthetic cannabinoid. Its chemical structure includes a methyl ester group and a pentyl chain, which contribute to its high affinity for cannabinoid receptors. The compound is typically synthesized in clandestine laboratories and sold in various forms, including powders and herbal mixtures.
Pharmacology[edit]
MDMB-4en-PINACA acts as a full agonist at the CB1 and CB2 receptors, which are primarily responsible for the psychoactive effects of cannabinoids. The activation of these receptors by MDMB-4en-PINACA can lead to effects similar to those of tetrahydrocannabinol (THC), the active component of cannabis, but often with greater potency and risk of adverse effects.
Effects and Risks[edit]
The use of MDMB-4en-PINACA can result in a range of effects, including euphoria, altered perception, and relaxation. However, due to its high potency, it can also cause severe adverse effects such as tachycardia, hypertension, nausea, vomiting, anxiety, paranoia, and hallucinations. In some cases, it has been associated with seizures and acute kidney injury.
Legal Status[edit]
Due to its potential for abuse and lack of medical use, MDMB-4en-PINACA is classified as a controlled substance in many countries. It is often included in legislation targeting synthetic cannabinoids and other novel psychoactive substances.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian